![](/images/graphics-bg.png)
Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
Joint Authors
Inotai, Andras
Csanadi, Marcell
Petrova, Guenka
Dimitrova, Maria
Bochenek, Tomasz
Tesar, Tomas
York, Kristina
Fuksa, Leos
Kostyuk, Alexander
Lorenzovici, Laszlo
Omelyanovskiy, Vitaly
Egyed, Katalin
Kalo, Zoltan
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-01-10
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
This policy research aims to map patient access barriers to biologic treatments, to explore how increased uptake of biosimilars may lower these hurdles and to identify factors limiting the increased utilisation of biosimilars.
A policy survey was developed to review these questions in 10 Central and Eastern European (CEE) and Commonwealth of Independent States (CIS) countries.
Two experts (one public and one private sector representative) from each country completed the survey.
Questions were related to patient access, purchasing, clinical practice, and real-world data collection on both original biologics and biosimilars.
Restrictions on the number of patients that can be treated and related waiting lists were reported as key patient access barriers.
According to respondents, for both clinicians and payers the primary benefit of switching patients to biosimilars would be to treat more patients.
However, concerns with therapeutic equivalence and fear of immunogenicity may reduce utilisation of biosimilars.
Similar limitations in patient access to both original biologics and biosimilars raise concerns about the appropriateness and success of current biosimilar policies in CEE and CIS countries.
The conceptual framework for additional real-world data collection exists in all countries which may provide a basis for future risk-management activities including vigorous pharmacovigilance data collection.
American Psychological Association (APA)
Inotai, Andras& Csanadi, Marcell& Petrova, Guenka& Dimitrova, Maria& Bochenek, Tomasz& Tesar, Tomas…[et al.]. 2018. Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1129884
Modern Language Association (MLA)
Inotai, Andras…[et al.]. Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1129884
American Medical Association (AMA)
Inotai, Andras& Csanadi, Marcell& Petrova, Guenka& Dimitrova, Maria& Bochenek, Tomasz& Tesar, Tomas…[et al.]. Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1129884
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1129884